Anticancer peptides (ACPs) play a vital role in selectively targeting and eliminating cancer
cells. Evaluating and comparing predictions from various machine learning (ML) and deep …

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, are multi-factor induced
neurological disorders that require management from multiple pathologies. The peptides …

Purpose Cancer stands as a significant global public health concern, with traditional
therapies potentially yielding severe side effects. Peptide-based cancer therapy is …

Anticancer peptides (ACPs) demonstrate significant potential in clinical cancer treatment
due to their ability to selectively target and kill cancer cells. In recent years, numerous …

Parkinson's disease (PD) is a neurological disorder caused by degeneration of
dopaminergic neurons in the midbrain. PD patients mainly suffer from motor symptoms …

Cancer is one of the main diseases threatening human life, accounting for millions of deaths
around the world each year. Traditional physical and chemical methods for cancer treatment …

Cancer, recognized as a primary cause of death worldwide, has profound health
implications and incurs a substantial social burden. Numerous efforts have been made to …

Anticancer peptides (ACPs) are a group of peptides that exhibit antineoplastic properties.
The utilization of ACPs in cancer prevention can present a viable substitute for conventional …

Human leukocyte antigen (HLA) molecules play critically significant role within the realm of
immunotherapy due to their capacities to recognize and bind exogenous antigens such as …

Anticancer peptides (ACPs) have emerged as one of the most promising therapeutic agents
for cancer treatment. They are bioactive peptides featuring broad-spectrum activity and low …